References
1. Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia.
Lancet 2011;377(9773):1264-1275.
2. Singleton RJ, Holman RC, Folkema AM, Wenger JD, Steiner CA, Redd JT.
Trends in lower respiratory tract infection hospitalizations among
American Indian/Alaska Native children and the general US child
population. J Pediatr 2012;161(2).
3. Hasegawa K, Tsugawa Y, Brown DFM, Mansbach JM, Camargo CA. Trends in
bronchiolitis hospitalizations in the United States, 2000-2009.
Pediatrics 2013;132(1):28-36.
4. Florin TA, Plint AC, Zorc JJ. Viral bronchiolitis. Lancet
2017;389(10065):211-224.
5. Asner SA, Science ME, Tran D, Smieja M, Merglen A, Mertz D. Clinical
disease severity of respiratory viral coinfection versus single viral
infection: A systematic review and meta-analysis. PLoS One 2014;9(6).
6. Richard N, Komurian-Pradel F, Javouhey E, Perret M, Rajoharison A,
Bagnaud A, Billaud G, Vernet G, Lina B, Floret D, et al. The impact of
dual viral infection in infants admitted to a pediatric intensive care
unit associated with severe bronchiolitis. Pediatr Infect Dis J
2008;27(3):213-217.
7. Brand HK, De Groot R, Galama JMD, Brouwer ML, Teuwen K, Hermans PWM,
Melchers WJG, Warris A. Infection with multiple viruses is not
associated with increased disease severity in children with
bronchiolitis. Pediatr Pulmonol 2012;47(4):393-400.
8. Eşki A, Öztürk GK, Gülen F, Çiçek C, Demir E. Risk factors for
infuenza virus related severe lower respiratory tract infection in
children. Pediatr Infect Dis J 2019;38(11):1090-1095.
9. Scotta MC, Chakr VCBG, de Moura A, Becker RG, de Souza APD, Jones MH,
Pinto LA, Sarria EE, Pitrez PM, Stein RT, et al. Respiratory viral
coinfection and disease severity in children: A systematic review and
meta-analysis. J Clin Virol 2016;80:45-56.
10. Goka EA, Vallely PJ, Mutton KJ, Klapper PE. Single and multiple
respiratory virus infections and severity of respiratory disease: A
systematic review. Paediatr Respir Rev 2014;15(4):363-370.
11. WHO. Pocket Book of Hospital Care for Children: Guidelines for the
Management of Common Childhood Illnesses. 2013.
12. Raymond J, Aujard Y. Nosocomial Infections in Pediatric Patients A
European, Multicenter Prospective Study. Infect Control
2000;21(4):260-263.
13. Asner SA, Rose W, Petrich A, Richardson S, Tran DJ. Is virus
coinfection a predictor of severity in children with viral respiratory
infections? Clin Microbiol Infect 2015;21(3):264.e1-264.e6.
14. Jackson S, Mathews KH, Pulanić D, Falconer R, Rudan I, Campbell H,
Nair H. Risk factors for severe acute lower respiratory infections in
children - a systematic review and meta-analysis. Croat Med J
2013;54(2):110-121.
15. Sonego M, Pellegrin MC, Becker G, Lazzerini M. Risk factors for
mortality from acute lower respiratory infections (ALRI) in children
under five years of age in low and middle-income countries: A systematic
review and meta-analysis of observational studies. PLoS One 2015;10(1).
16. Mazur NI, Bont L, Cohen AL, Cohen C, Von Gottberg A, Groome MJ,
Hellferscee O, Klipstein-Grobusch K, Mekgoe O, Naby F, et al. severity
of respiratory syncytial virus lower respiratory tract infection with
viral coinfection in HIV-uninfected children. Clin Infect Dis
2017;64(4):443-450.
17. Statement P. Updated Guidance for Palivizumab Prophylaxis Among
Infants and Young Children at Increased Risk of Hospitalization for
Respiratory Syncytial Virus Infection. 2017.
18. Das MK, Bhattacharyya N, Bhattacharyya AK. WHO child growth
standards. 2010.
19. Lanzkowsky’s Manual of Pediatric Hematology and Oncology. 2016.
20. Cangiano G, Nenna R, Frassanito A, Evangelisti M, Nicolai A,
Scagnolari C, Pierangeli A, Antonelli G, Papoff P, Petrarca L, et al.
Bronchiolitis: Analysis of 10 consecutive epidemic seasons. Pediatr
Pulmonol 2016;51(12):1330-1335.
21. Martínez-Roig A, Salvadó M, Caballero-Rabasco MA, Sánchez-Buenavida
A, López-Segura N, Bonet-Alcaina M. Viral Coinfection in Childhood
Respiratory Tract Infections. Arch Bronconeumol 2015;51(1):5-9.
22. Harada Y, Kinoshita F, Yoshida LM, Le Nhat M, Suzuki M, Morimoto K,
Toku Y, Tomimasu K, Moriuchi H, Ariyoshi K. Does respiratory virus
coinfection increases the clinical severity of acute respiratory
infection among children infected with respiratory syncytial virus?
Pediatr Infect Dis J 2013;32(5):441-445.
23. Semple MG, Cowell A, Dove W, Greensill J, McNamara PS, Halfhide C,
Shears P, Smyth RL, Hart CA. Dual Infection of Infants by Human
Metapneumovirus and Human Respiratory Syncytial Virus Is Strongly
Associated with Severe Bronchiolitis. J Infect Dis 2005;191(3):382-386.
24. Hammer J, Numa A, Newth CJL. Acute respiratory distress syndrome
caused by respiratory syncytial virus. Pediatr Pulmonol
1997;23(3):176-183.
25. DaPalma T, Doonan BP, Trager NM, Kasman LM. A systematic approach to
virus-virus interactions. Virus Res 2010;149(1):1-9.
26. McCullers JA. The co-pathogenesis of influenza viruses with bacteria
in the lung. Nat Rev Microbiol 2014;12(4):252-262.
27. Costa LF, Oliveira Queiróz DA, Lopes Da Silveira H, Bernardino Neto
M, De Paula NT, Oliveira TFMS, Tolardo AL, Yokosawa J. Human rhinovirus
and disease severity in children. Pediatrics 2014;133(2).
28. Xatzipsalti M, Psarros F, Konstantinou G, Gaga M, Gourgiotis D,
Saxoni-Papageorgiou P, Papadopoulos NG. Modulation of the epithelial
inflammatory response to rhinovirus in an atopic environment. Clin Exp
Allergy 2008;38(3):466-472.
29. Lee WM, Lemanske RF, Evans MD, Vang F, Pappas T, Gangnon R, Jackson
DJ, Gern JE. Human rhinovirus species and season of infection determine
illness severity. Am J Respir Crit Care Med 2012;186(9):886-891.
30. de Souza WM, Buss LF, Candido D da S, Carrera JP, Li S, Zarebski AE,
Pereira RHM, Prete CA, de Souza-Santos AA, Parag K V., et al.
Epidemiological and clinical characteristics of the COVID-19 epidemic in
Brazil. Nat Hum Behav 2020;4(8):856-865.
31. Zimmermann P, Curtis N. COVID-19 in Children, Pregnancy and
Neonates: A Review of Epidemiologic and Clinical Features. Pediatr
Infect Dis J 2020:469-477.
32. Lansbury L, Lim B, Baskaran V, Lim WS. Coinfections in people with
COVID-19: a systematic review and meta-analysis. J Infect
2020;81(2):266-275.
33. Shah NS, Greenberg JA, McNulty MC, Gregg KS, Riddell J, Mangino JE,
Weber DM, Hebert CL, Marzec NS, Barron MA, et al. Bacterial and viral
coinfections complicating severe influenza: Incidence and impact among
507 U.S. patients, 2013-14. J Clin Virol 2016;80:12-19.
34. Jefferson T, Jones MA, Doshi P, Del Mar CB, Hama R, Thompson MJ,
Spencer EA, Onakpoya IJ, Mahtani KR, Nunan D, et al. Neuraminidase
inhibitors for preventing and treating influenza in adults and children.
Cochrane Database Syst Rev 2014;2014(4).
35. Uršič T, Steyer A, Kopriva S, Kalan G, Krivec U, Petrovec M. Human
bocavirus as the cause of a life-threatening infection. J Clin Microbiol
2011;49(3):1179-1181.
36. Knott AM, Long CE, Hall CB. Parainfluenza viral infections in
pediatric outpatients: Seasonal patterns and clinical characteristics.
Pediatr Infect Dis J 1994;13(4):269-273.
37. Lee MS, Walker RE, Mendelman PM. Medical burden of respiratory
syncytial virus and parainfluenza virus type 3 infection among US
children. Implications for design of vaccine trials. Hum Vaccin
2005;1(1):6-11.
38. WHO. WHO report on the global tobacco epidemic. 2008 [accessed
2020 May 27].
https://www.who.int/tobacco/surveillance/policy/country_profile/tur.pdf?ua=1
39. Browne MJ. Comparative inhibition of influenza and parainfluenza
virus replication by ribavirin in MDCK cells. Antimicrob Agents
Chemother 1981;19(5):712-715.
40. O’Donnell DR, Carrington D. Peripheral blood lymphopenia and
neutrophilia in children with severe respiratory syncytial virus
disease. Pediatr Pulmonol 2002;34(2):128-130.